DIVERSITY AND SELECTION IN BABESIA-BOVIS AND THEIR IMPACT ON VACCINE USE
被引:16
作者:
DALRYMPLE, BP
论文数: 0引用数: 0
h-index: 0
机构:Brian Darlymple is at CSIRO, Division of Tropical Animal Production, Long Pocket Laboratories, Indooroopilly, QLD 4068, Private Bag No. 3, PO
DALRYMPLE, BP
机构:
[1] Brian Darlymple is at CSIRO, Division of Tropical Animal Production, Long Pocket Laboratories, Indooroopilly, QLD 4068, Private Bag No. 3, PO
来源:
PARASITOLOGY TODAY
|
1992年
/
8卷
/
01期
关键词:
D O I:
10.1016/0169-4758(92)90306-M
中图分类号:
R38 [医学寄生虫学];
Q [生物科学];
学科分类号:
07 ;
0710 ;
09 ;
100103 ;
摘要:
In the post few years the prospect of a recombinant vaccine effective against the cattle haemoparasite Babesia bovis has almost become a reality. However, in Australia, vaccination with live parasites has been practised since before the turn of the century and it has recently been proposed that selection of parasites resistant to immunity induced by the B. bovis line Ka (since 1979 the only component of the live attenuated vaccine) may have occurred. Brian Dalrymple examines the evidence for and against this proposal and discusses examples of strain diversity and variation and their effect on the long-term viability of defined attenuated and recombinant vaccines.